FDA Person
Division of Advertising & Promotion Robert Dean
View detailed information about Robert Dean, including compliance records, violations, and related data.
Person Profile
FDA investigator, Division of Advertising & Promotion.
Documents (9)
- WARNING LETTER · Metuchen Pharmaceuticals, LLC. · September 3, 2019
- WARNING LETTER · Currax Pharmaceuticals LLC · September 3, 2020
- WARNING LETTER · CooperSurgical, Inc. · February 23, 2021
- WARNING LETTER · Nephron Sc Inc · September 22, 2020
- WARNING LETTER · Johnson & Johnson Pharmaceutical Research and Development, L.L.C. · September 25, 2008
- WARNING LETTER · Mallinckrodt Inc. · September 25, 2008
- WARNING LETTER · Nalpropion Pharmaceuticals LLC · September 29, 2020
- WARNING LETTER · Novartis Pharmaceuticals Corp · September 25, 2008
- WARNING LETTER · IPR Pharmaceuticals, Inc. · August 31, 2020
Related Office
Person Information
Name
Robert Dean
Title
Director
Role
Regulatory Personnel
ID: 6971bf6a-a3ee-42a5-bc4b-e88ad85df505
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.